Cargando…

Metabolomics Analysis for Defining Serum Biochemical Markers in Colorectal Cancer Patients with Qi Deficiency Syndrome or Yin Deficiency Syndrome

Colorectal cancer is one of the leading causes of tumor-associated death, and traditional Chinese medicine (TCM) classifies colorectal cancer into various subtypes mainly according to the symptomatic pattern identification (ZHENG). Here, we investigated the difference in metabolic profiles of serum...

Descripción completa

Detalles Bibliográficos
Autores principales: Tao, Fangfang, Lü, Ping, Xu, Chunbo, Zheng, Mengmeng, Liu, Wenhong, Shen, Minhe, Ruan, Shanming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5546053/
https://www.ncbi.nlm.nih.gov/pubmed/28811829
http://dx.doi.org/10.1155/2017/7382752
_version_ 1783255518575329280
author Tao, Fangfang
Lü, Ping
Xu, Chunbo
Zheng, Mengmeng
Liu, Wenhong
Shen, Minhe
Ruan, Shanming
author_facet Tao, Fangfang
Lü, Ping
Xu, Chunbo
Zheng, Mengmeng
Liu, Wenhong
Shen, Minhe
Ruan, Shanming
author_sort Tao, Fangfang
collection PubMed
description Colorectal cancer is one of the leading causes of tumor-associated death, and traditional Chinese medicine (TCM) classifies colorectal cancer into various subtypes mainly according to the symptomatic pattern identification (ZHENG). Here, we investigated the difference in metabolic profiles of serum by comparing colorectal cancer subjects with Nondeficiency (ND), Qi deficiency (QD), and Yin deficiency (YD). The ratio of subjects with carcinoembryonic antigen (CEA) was higher in YD pattern, and the ratio of subjects with carbohydrate antigen 19-9 (CA19-9) was higher both in YD and in QD, compared with ND. As a result of metabolomics analysis, twenty-five metabolites displayed differences between QD and ND, while twenty-eight metabolites displayed differences between YD and ND. The downregulated metabolites in QD/ND and YD/ND mainly include carbohydrates and the upregulated metabolites mainly include amino acids and fatty acids, suggesting conversion obstruction of carbohydrates, fatty acids, and amino acids occurs in patients with QD and YD compared with ND. Our results demonstrate that colorectal cancer patients with QD or YD were associated with metabolic disorders and the variations of serum metabolic profiles may serve as potential biochemical markers for diagnosis and prognosis of colorectal cancer patients displayed QD or YD patterns.
format Online
Article
Text
id pubmed-5546053
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-55460532017-08-15 Metabolomics Analysis for Defining Serum Biochemical Markers in Colorectal Cancer Patients with Qi Deficiency Syndrome or Yin Deficiency Syndrome Tao, Fangfang Lü, Ping Xu, Chunbo Zheng, Mengmeng Liu, Wenhong Shen, Minhe Ruan, Shanming Evid Based Complement Alternat Med Research Article Colorectal cancer is one of the leading causes of tumor-associated death, and traditional Chinese medicine (TCM) classifies colorectal cancer into various subtypes mainly according to the symptomatic pattern identification (ZHENG). Here, we investigated the difference in metabolic profiles of serum by comparing colorectal cancer subjects with Nondeficiency (ND), Qi deficiency (QD), and Yin deficiency (YD). The ratio of subjects with carcinoembryonic antigen (CEA) was higher in YD pattern, and the ratio of subjects with carbohydrate antigen 19-9 (CA19-9) was higher both in YD and in QD, compared with ND. As a result of metabolomics analysis, twenty-five metabolites displayed differences between QD and ND, while twenty-eight metabolites displayed differences between YD and ND. The downregulated metabolites in QD/ND and YD/ND mainly include carbohydrates and the upregulated metabolites mainly include amino acids and fatty acids, suggesting conversion obstruction of carbohydrates, fatty acids, and amino acids occurs in patients with QD and YD compared with ND. Our results demonstrate that colorectal cancer patients with QD or YD were associated with metabolic disorders and the variations of serum metabolic profiles may serve as potential biochemical markers for diagnosis and prognosis of colorectal cancer patients displayed QD or YD patterns. Hindawi 2017 2017-07-24 /pmc/articles/PMC5546053/ /pubmed/28811829 http://dx.doi.org/10.1155/2017/7382752 Text en Copyright © 2017 Fangfang Tao et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Tao, Fangfang
Lü, Ping
Xu, Chunbo
Zheng, Mengmeng
Liu, Wenhong
Shen, Minhe
Ruan, Shanming
Metabolomics Analysis for Defining Serum Biochemical Markers in Colorectal Cancer Patients with Qi Deficiency Syndrome or Yin Deficiency Syndrome
title Metabolomics Analysis for Defining Serum Biochemical Markers in Colorectal Cancer Patients with Qi Deficiency Syndrome or Yin Deficiency Syndrome
title_full Metabolomics Analysis for Defining Serum Biochemical Markers in Colorectal Cancer Patients with Qi Deficiency Syndrome or Yin Deficiency Syndrome
title_fullStr Metabolomics Analysis for Defining Serum Biochemical Markers in Colorectal Cancer Patients with Qi Deficiency Syndrome or Yin Deficiency Syndrome
title_full_unstemmed Metabolomics Analysis for Defining Serum Biochemical Markers in Colorectal Cancer Patients with Qi Deficiency Syndrome or Yin Deficiency Syndrome
title_short Metabolomics Analysis for Defining Serum Biochemical Markers in Colorectal Cancer Patients with Qi Deficiency Syndrome or Yin Deficiency Syndrome
title_sort metabolomics analysis for defining serum biochemical markers in colorectal cancer patients with qi deficiency syndrome or yin deficiency syndrome
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5546053/
https://www.ncbi.nlm.nih.gov/pubmed/28811829
http://dx.doi.org/10.1155/2017/7382752
work_keys_str_mv AT taofangfang metabolomicsanalysisfordefiningserumbiochemicalmarkersincolorectalcancerpatientswithqideficiencysyndromeoryindeficiencysyndrome
AT luping metabolomicsanalysisfordefiningserumbiochemicalmarkersincolorectalcancerpatientswithqideficiencysyndromeoryindeficiencysyndrome
AT xuchunbo metabolomicsanalysisfordefiningserumbiochemicalmarkersincolorectalcancerpatientswithqideficiencysyndromeoryindeficiencysyndrome
AT zhengmengmeng metabolomicsanalysisfordefiningserumbiochemicalmarkersincolorectalcancerpatientswithqideficiencysyndromeoryindeficiencysyndrome
AT liuwenhong metabolomicsanalysisfordefiningserumbiochemicalmarkersincolorectalcancerpatientswithqideficiencysyndromeoryindeficiencysyndrome
AT shenminhe metabolomicsanalysisfordefiningserumbiochemicalmarkersincolorectalcancerpatientswithqideficiencysyndromeoryindeficiencysyndrome
AT ruanshanming metabolomicsanalysisfordefiningserumbiochemicalmarkersincolorectalcancerpatientswithqideficiencysyndromeoryindeficiencysyndrome